THY1 and glomerulonephritis: We utilized anti-Thy1 antibody to target CD90 (Thy1) to induce glomerulonephritis in Sprague Dawley rats, and our findings suggest that daily administration of everolimus to anti-Thy1-injected rats reduced markers of renal injury and glomerular damage.